Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

NCT06421376 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Immunotherapy
Induction Therapy
Chemoradiotherapy
Surgery

Interventions

DRUG: Cardonilizumab
RADIATION: Chemoradiotherapy ±immunotherapy
PROCEDURE: Radical surgery

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences